Toggle light / dark theme

Artist’s concept of primary tumor (credit: Barts Cancer Institute/QMUL)

Metastasis (spread of cancer) is one of the biggest challenges in cancer treatment. It is often not the original tumor that kills, but secondary growths. But a key question in cancer research has been how vulnerable cancer cells are able to survive once they break away from a tumor to spread around the body.

“Metastasis is currently incurable and remains one of the key targets of cancer research,” said lead researcher Stéphanie Kermorgant, PhD, from Barts Cancer Institut at Queen Mary University of London (QMUL). “Our research advances the knowledge of how two key molecules communicate and work together to help cancer cells survive during metastasis. We’re hoping that this might lead to the discovery of new drugs to block the spread of cancer within the body.”

Metastasizing cancer cells, as one enters a blood vessel (artist’s concept) (credit: Barts Cancer Institute/QMUL)

The study, published in an open-access paper in Nature Communications, examined the changes that occur in cancer cells as they break away from tumors in cell cultures in mice and zebrafish. The research revealed a previously unknown survival mechanism in cancer cells and found that molecules known as “integrins” could be key.

Read more

My new Psychology Today story on BREXIT and the EU:


Scientific innovation doesn’t just happen on its own. It takes stable economies, free societies, and open-minded governments. The best environment for science to thrive in is that of collaborating groups incentivized to communicate and cooperate with one another. This is precisely what the European Union is.

And now, more than ever, the union of Europe is needed—because we are crossing over into the transhumanist age, where radical science and technology will engulf our lives and challenge our institutions. Robots will take 75% of the jobs in the next 25 years. CRISPR gene editing technology will allow us to augment our intelligence, perhaps doubling our IQ. Bionic organs will stave off death, allowing 200 year lifespans.

The science and technology coming in just the next two decades will cause unprecedented challenges to humanity. Most of the world will get chip implants— I have one —to assist with quick payments, emergency tracking, and to replace archaic accessories like car keys. We’ll also all use genetic therapies to cure cancer, heart disease, Alzheimer’s, and even aging. And robots will be ubiquitous—driving us everywhere, homeschooling our children, and maybe even becoming preferred sexual partners.

Read more

Excellent!!! Cannot wait until we eradicate cancer, MS, Parkinson, Dystonia, Cystic-Fibrosis, LGD, etc.


A team of Physicians at the University of Pennsylvania’s School of Medicine now has their project of modifying the immune cells of 18 different cancer patients with the CRISPR-Cas9 system approved by the National Institute of Health.

CRISPR is the gift that keeps on giving—when it’s not fighting blindness, tackling HIV, or even recording real-time immune responses, it is taking on the emperor of all maladies: cancer.

But what’s even more fascinating about this use of CRISPR is that the National Institute of Health’s (NIH) Recombinant DNA Research Advisory Committee (RAC) has approved the first-ever use of CRISPR in human cancer therapy, a monumental step in the history of the gene-editing technology.

Read more

3D Printing never ceases to amaze me.


Doctors at Boston Children’s Hospital used a 3D printout of a boy’s skull to prepare for the surgery that saved his life, STAT reports.

Bentley Yoder was born with encephalocele, a rare and often fatal defect in which the skull doesn’t form properly. In Bentley’s case, a significant portion of his brain grew outside of his skull, according to STAT. Despite being told he would not survive, his parents, Dustin and Sierra, continued to seek treatment that would give their son a future, eventually traveling from their home in Ohio to Boston Children’s Hospital.

Aided by 3D models of Bentley’s brain, Dr. John Meara performed the risky surgery on May 24 to save the 7-month-old’s life.

Read more

Who needs cloning or gene editing; when you have 3D printers.


Although—in the grand scheme of things—3D printing is a relatively new technology in the eyes of humanity, that certainly doesn’t mean that it can’t be used to recreate some of the most ancient artifacts and fossils scattered throughout the Earth. Over the past year, we’ve seen 3D printing technology help recreate the oldest chameleon fossil ever found, as well as a 1220-foot Titanosaur fossil. Even some of the world’s tiniest fossils have been digitally resized and 3D printed so that a paleontologist from the University of Oxford could better examine them. Now, trilobites, which are a group of extinct marine arthropods, are undergoing their own unique form of 3D printed treatment.

Dr. Gianpaolo Di Silvestro, established paleontologist and CEO of the Italian company Trilobite Design Italia, specializes in this group of extinct arthropods, and uses his company to sell both original trilobite fossils and model replicas to collectors, institutions, and museums across the globe. After realizing that a great number of museums were able to provide text information on these fossils, but not a true physical representation, Dr. Di Silvestro decided to provide these museums with palpable trilobite models that would allow visitors to actually hold the ancient past in the palms of their hands. Since traditional fossil casting and modeling proved to be much too costly and time-consuming, Dr. Di Silvestro instead collaborated with Italian architect and 3D designer Francesco Baldassare to work in tandem and design accurate 3D models of trilobites.

FullSizeRender-2-768x1024

Although a number of 3D printing service bureaus rejected Dr. Di Silvestro’s 3D fossil models due to their design complexity, the Materialise office in Italy rose to the occasion and helped bring these trilobites back to our physical reality. For Dr. Di Silvestro and Baldassare, Materialise’s 3D printing technology has provided them with the ideal solution.

Read more

Scientists are one step closer to using CRISPR gene editing on humans, with a US federal advisory panel approving the use of the technique for a study led by the University of Pennsylvania.

The scientists are seeking to use the CRISPR-Cas9 technique to create genetically altered T cells – white blood cells that play an important role in our immune system – that are more effective at fighting cancer cells in patients with melanoma, multiple myeloma, and sarcoma.

“Our preliminary data suggests that we could improve the efficacy of these T cells if we use CRISPR,” lead researcher Carl June told the National Institute of Health’s (NIH) Recombinant DNA Advisory Committee (RAC) on Tuesday.

Read more

In 2009, President Obama pledged to “restore science to its rightful place.” He said, “We will not just meet, but we will exceed the level achieved at the height of the space race, through policies that invest in basic and applied research, create new incentives for private innovation, promote breakthroughs in energy and medicine, and improve education in math and science.”

Today, the White House released an Impact Report listing 100 things that Obama has made happen with the support of many people across research, policy, education, and, yes, maker culture. Here’s the full Impact Report. A few examples from the list:

Read more

In Russia, not all scientific projects get financial backing from the government — but teleportation does.

On June 22, a special interagency working group, along with Russian Deputy Prime Minister Arkady Dvorkovich, discussed the country’s scientific and technological plans drawn up by the Russian Strategic Initiatives Agency.

The document, described in detail by Kommersant newspaper, lists innovations Russian scientists plan to accomplish by 2035. Among them are a Russia-based coding language, a 5G mobile network, “smart” buildings, medical implants — and teleportation.

Read more